Screener
McKesson MCK Prescription Technology Solutions — Total reserve balance
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by McKesson in its filing.
Tagged under the XBRL concept us-gaap:RestructuringReserve.
The source filing: McKesson’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:29 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000927653-26-000234
| (In millions) | North American Pharmaceutical | Prescription Technology Solutions | Medical-Surgical Solutions | Corporate | Total |
|---|---|---|---|---|---|
| Balance, March 31, 2026 (1) | $18 | $3 | $10 | $13 | $44 |
| Restructuring, impairment, and related charges, net | 2 | 61 | 23 | 50 | 136 |
| Non-cash charges | (1) | (40) | — | (6) | (47) |
| Cash payments | (3) | — | (16) | (40) | (59) |
| Balance, June 30, 2026 (2) | $16 | $24 | $17 | $17 | $74 |
Item 1. Condensed Consolidated Financial Statements.
FAQ
- What is McKesson's prescription technology solutions — total reserve balance?
- McKesson (MCK) reported prescription technology solutions — total reserve balance of $24M in Q2 2026.
- How has McKesson's prescription technology solutions — total reserve balance changed year-over-year?
- McKesson's prescription technology solutions — total reserve balance increased by 2300.0% year-over-year, from $1M to $24M.
- What does prescription technology solutions — total reserve balance mean?
- Represents the cumulative balance of accruals set aside for specific liabilities related to the Prescription Technology Solutions segment, such as restructuring or legal contingencies. This balance provides insight into the company's expected future cash outflows for these specific obligations.
Ask your AI about McKesson's prescription technology solutions — total reserve balance.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude